Some trends which are happening in the Global CRO market
Market share gains made by larger contract research organisations (CRO) will be underpinned by strategic partnerships.
Strategic outsourcing by Pfizer and its peers will boost the market share of the big six public CROs – Covance, PPD, Parexel, Charles River, Icon and Kendle – and Quintiles. In 2010 these companies had 41 per cent of the market; by 2015 Windley predicts they will have 49 per cent.
In light of this trend many have predicted the CRO sector will split into two groups : large, global service providers working in strategic, high-level relationships; and niche providers focused on one or two therapeutic areas.